OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MDMA for the Treatment of Negative Symptoms in Schizophrenia
Mitchell Arnovitz, Andrew J. Spitzberg, Ashkhan J. Davani, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3255-3255
Open Access | Times Cited: 22
Mitchell Arnovitz, Andrew J. Spitzberg, Ashkhan J. Davani, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3255-3255
Open Access | Times Cited: 22
Showing 22 citing articles:
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies
Natacha Perez, Florent Langlest, Luc Mallet, et al.
European Neuropsychopharmacology (2023) Vol. 76, pp. 61-76
Open Access | Times Cited: 44
Natacha Perez, Florent Langlest, Luc Mallet, et al.
European Neuropsychopharmacology (2023) Vol. 76, pp. 61-76
Open Access | Times Cited: 44
Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting
Dimitri Perivoliotis, Kayla Knopp, Shannon Remick, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Dimitri Perivoliotis, Kayla Knopp, Shannon Remick, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
EMBARK Psychedelic Therapy for Depression
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2
Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychopathological Psychotic Experiences and Psychotic Disorders
Joseph La Torre, Mehdi Mahammadli, Sonya C. Faber, et al.
International Journal of Mental Health and Addiction (2023) Vol. 22, Iss. 2, pp. 913-937
Closed Access | Times Cited: 5
Joseph La Torre, Mehdi Mahammadli, Sonya C. Faber, et al.
International Journal of Mental Health and Addiction (2023) Vol. 22, Iss. 2, pp. 913-937
Closed Access | Times Cited: 5
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies
Michel Sabé, Adi Sulstarova, Alban Glangetas, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 1
Michel Sabé, Adi Sulstarova, Alban Glangetas, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 1
Linking Substance Use and Schizophrenia
Emre Mutlu, Hayri Can Özden, Aygün Ertuğrul
Springer eBooks (2024), pp. 1-26
Closed Access
Emre Mutlu, Hayri Can Özden, Aygün Ertuğrul
Springer eBooks (2024), pp. 1-26
Closed Access
Considerations Prior to Meeting With a Participant
Bill Brennan, Alex Belser
(2024), pp. 93-131
Closed Access
Bill Brennan, Alex Belser
(2024), pp. 93-131
Closed Access
INTRODUCTION: A New Approach for the Whole Person
Bill Brennan, Alex Belser
(2024), pp. 1-9
Closed Access
Bill Brennan, Alex Belser
(2024), pp. 1-9
Closed Access
Working Within the EMBARK Domains Cheat Sheet
Bill Brennan, Alex Belser
(2024), pp. 268-268
Closed Access
Bill Brennan, Alex Belser
(2024), pp. 268-268
Closed Access
EMBARK Mechanisms of Change in the Treatment of Depression
Bill Brennan, Alex Belser
(2024), pp. 70-92
Closed Access
Bill Brennan, Alex Belser
(2024), pp. 70-92
Closed Access
Investigating the impact of psychedelic drugs on social cognition defects: A scoping review protocol
Sarah A. Smith, S. Smith, Liz Dennett, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307491-e0307491
Open Access
Sarah A. Smith, S. Smith, Liz Dennett, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307491-e0307491
Open Access
